Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve the Un-Audited Financial ....
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals has informed the stock exchanges that its Board of Directors will meet on November 11, 2025 to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2025. The trading window for designated persons and their immediate relatives has been closed from October 1, 2025 to November 13, 2025 in line with insider trading rules. No financial figures, projections, or business updates have been disclosed in this intimation.
This is a routine regulatory filing with no direct impact on shareholders. Investors should watch for the actual Q2/H1 results post the board meeting for any meaningful update on revenue, profits, or margins.